HighTower Advisors LLC Purchases 138,145 Shares of Encompass Health Corporation $EHC

HighTower Advisors LLC boosted its position in shares of Encompass Health Corporation (NYSE:EHC - Free Report) by 804.4% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 155,318 shares of the company's stock after acquiring an additional 138,145 shares during the quarter. HighTower Advisors LLC owned 0.16% of Encompass Health worth $15,700,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in the company. California State Teachers Retirement System raised its holdings in shares of Encompass Health by 9,758.8% in the 2nd quarter. California State Teachers Retirement System now owns 11,605,197 shares of the company's stock valued at $1,173,053,000 after purchasing an additional 11,487,483 shares during the period. BlackRock Inc. bought a new position in Encompass Health during the second quarter worth about $1,059,762,000. Northwestern Mutual Wealth Management Co. grew its holdings in Encompass Health by 3,059,159.7% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,793,482 shares of the company's stock worth $402,640,000 after purchasing an additional 3,793,358 shares during the period. Norges Bank acquired a new position in Encompass Health during the fourth quarter worth approximately $133,221,000. Finally, William Blair Investment Management LLC bought a new stake in Encompass Health in the second quarter valued at approximately $116,352,000. Institutional investors and hedge funds own 97.25% of the company's stock.

Insider Transactions at Encompass Health

In other Encompass Health news, EVP John Darby sold 8,906 shares of the stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $125.95, for a total transaction of $1,121,710.70. Following the transaction, the executive vice president owned 75,041 shares in the company, valued at $9,451,413.95. This represents a 10.61% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Mark J. Tarr sold 173,148 shares of Encompass Health stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $125.47, for a total transaction of $21,724,879.56. Following the completion of the sale, the chief executive officer owned 267,814 shares of the company's stock, valued at approximately $33,602,622.58. The trade was a 39.27% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 186,912 shares of company stock worth $23,434,845. 1.80% of the stock is owned by insiders.

Encompass Health Price Performance

Shares of NYSE EHC opened at $121.52 on Thursday. The firm has a market cap of $11.99 billion, a P/E ratio of 19.79, a price-to-earnings-growth ratio of 2.44 and a beta of 0.75. The business's 50 day moving average is $116.54 and its 200-day moving average is $107.83. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.76. Encompass Health Corporation has a 1-year low of $92.77 and a 1-year high of $127.99.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The company reported $1.55 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.48 by $0.07. The business had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.57 billion. Encompass Health had a return on equity of 18.08% and a net margin of 10.01%.The firm's quarterly revenue was up 9.6% on a year-over-year basis. During the same period in the previous year, the company posted $1.40 EPS. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. Equities research analysts predict that Encompass Health Corporation will post 6.08 earnings per share for the current year.

Encompass Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Investors of record on Thursday, October 1st will be paid a $0.21 dividend. This represents a $0.84 annualized dividend and a dividend yield of 0.7%. This is a boost from Encompass Health's previous quarterly dividend of $0.19. The ex-dividend date is Thursday, October 1st. Encompass Health's dividend payout ratio is currently 12.38%.

Analysts Set New Price Targets

EHC has been the subject of several research analyst reports. Leerink Partners set a $152.00 target price on Encompass Health in a research note on Friday, May 22nd. Barclays raised their price target on Encompass Health from $140.00 to $144.00 and gave the company an "overweight" rating in a report on Thursday, August 6th. Wall Street Zen cut shares of Encompass Health from a "buy" rating to a "hold" rating in a research report on Saturday, September 5th. TD Cowen increased their price objective on shares of Encompass Health from $125.00 to $140.00 and gave the company a "buy" rating in a research report on Monday, August 10th. Finally, Weiss Ratings upgraded shares of Encompass Health from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Wednesday, August 12th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has assigned a Hold rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Buy" and a consensus price target of $146.83.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corporation (NYSE:EHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.